Physician profile
Liam Ortega
NPI 1770157604
$5,874.67
in general payments reported to CMS, 2019-2025
13 companies · $1,829 in 2025
The $1,829 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $187 · 2022: $2,836 · 2023: $907 · 2024: $115 · 2025: $1,829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,294 · Education: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,294.36 |
| Education | $556.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $2,423.41 | 2022 | |
| Stryker Corporation | $873.67 | 2022-2025 | Gamma, Variax, Hoffmann |
| Zimmer Biomet Holdings, INC. | $685.34 | 2025 | Comprehensive Shoulder System, Osseofit |
| Medical Device Business Services, INC. | $556.98 | 2025 | Actis |
| Smith+Nephew, INC. | $345.17 | 2022-2023 | Rf20000, Q-Fix, Bone Anchors With Arthroscopic Delivery System |
| Integra Lifesciences Corporation | $343.45 | 2021-2022 | |
| Depuy Synthes Sales INC. | $268.73 | 2025 | Na, Tfn-Advance |
| Organogenesis INC. | $118.96 | 2025 | Puraply Wound Matrix |
| Axogen | $100.85 | 2025 | |
| Endo Pharmaceuticals INC. | $99.88 | 2023 | Xiaflex |
| Nexus Medical Technologies LLC | $21.06 | 2025 | |
| Kci USA, INC. | $20.26 | 2023 | Prevena Restor Arthroform, V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Medtronic, INC. | $16.91 | 2023 | Mazor X System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liam Ortega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.